Trial intelligence / Profile preview

POEM: Synergy Stent with 1-Month DAPT in HBR Patients

NCT03112707Phase 4Unknown

Sponsor
Humanitas Research Hospital
Start
Apr 2017
Primary completion
May 2020
Countries
1
01

Overview

Phase 4, open-label, single-arm trial in coronary artery disease (CAD) and acute coronary syndrome (ACS), sponsored by Humanitas Research Hospital. Primary endpoint: Major Adverse Cardiac Events at 1 year. Status: unknown.

02

Conditions

coronary artery disease (CAD)acute coronary syndrome (ACS)

Beyond the preview

Go deeper on NCT03112707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03112707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call